period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.7,0.5,0,0.4166666666666667,[0],"The FDA is actively monitoring the market following reports of a manufacturer disruption. At present, supply remains adequate and no shortages have been confirmed. We encourage continued reporting from stakeholders to maintain timely information flow."
1,1.5,0.7,0.8,0,0.5333333333333333,[0],The FDA is monitoring the emerging shortage and encourages stakeholders to report any significant supply disruptions. Coordination efforts are underway to address production challenges.
2,1.5,0.7,0.8,0,0.5333333333333333,[0],The FDA is aware of the emerging supply shortage and is working closely with the affected manufacturer and other industry stakeholders to address the issue. We encourage healthcare providers to report any supply difficulties and assure the public that steps are being taken to stabilize the supply.
3,1.5,0.7,0.8,0,0.5333333333333333,[0],The FDA is aware of an emerging drug shortage and is coordinating with manufacturers to address supply issues. Stakeholders are encouraged to report any disruptions in distribution and to coordinate efforts to meet demand.
